| 獲證日 | 專利名稱 | 證號 |
| 2023/1/5 | 5-methoxytryptophan and its derivatives and uses thereof | NZ733731 |
| 2023/1/10 | Dipicolylamine derivatives and their pharmaceutical uses | CA2949663 |
| 2023/1/13 | Anti-Aβ antibodies and uses thereof | JP7210612 |
| 2023/1/24 | Benzimidazole compounds and use thereof for treating Alzheimer’s disease or Huntington’s disease | CA3109623 |
| 2023/1/27 | Benzimidazole compounds and use thereof for treating Alzheimer’s disease or Huntington’s disease | HK40053325 |
| 2023/2/10 | Heterocyclic compounds and use thereof | IN421151 |
| 2023/2/11 | 消除擴散磁振造影移動假影的方法 | TWI792513 |
| 2023/2/11 | 角膜保存液 | TWI792427 |
| 2023/3/1 | PTGR2抑制劑及其用途 | TWI795232 |
| 2023/3/3 | Benzimidazole compounds and use thereof for treating Alzheimer’s disease or Huntington’s disease | IN424040 |
| 2023/3/8 | Heterocyclic compounds and use thereof | KR10-2509431 |
| 2023/3/14 | Method of Producing Exosomes from Stem Cells and Use Thereof | JP7244988 |
| 2023/3/21 | Method and composition for decreasing the psychotomimetic side effect and addictive disorder of ketamine | CA3025484 |
| 2023/3/21 | Aminothiazole compounds as protein kinase inhibitors | CA3064081 |
| 2023/3/30 | Dual-Function Antibodies Targeting VEGFR2 and VEGFR3 | AU2019239984 |
| 2023/4/11 | Anti-RSPO3 antibodies | US11623951 |
| 2023/4/11 | Dual-Function Antibodies Targeting VEGFR2 and VEGFR3 | US11623960 |
| 2023/4/13 | Anti-Aβ antibodies and uses thereof | KR10-2523019 |
| 2023/4/21 | 多雜環小分子藥物偶合物及其用途 | TWI799896 |
| 2023/5/1 | 皮膚治療用之聚焦超音波裝置與方法 | TWI800656 |